Abstract: A motor vehicle includes an internal combustion engine, an after-treatment device to treat first exhaust gases produced by the internal combustion engine, a first exhaust line configured to feed the first exhaust gases to the after-treatment device, combustion means configured to produce second exhaust gases with a combustion chamber and an injector device that can be controlled to inject the fuel into the combustion chamber, a second exhaust line configured to feed the second exhaust gases to the after-treatment device, a tank to hold the fuel, and a supply line configured to feed a fuel stream from the tank to the injector device, the supply line comprising a valve that can be controlled according to at least one first control mode and a second control mode, wherein the valve respectively allows and prevents a fuel flow passage to the injector device.

Abstract: An engine system having an internal combustion engine that receives combustion air from an intake duct, and a tank for the oil, having an accumulation zone for gases containing oil vapors; the engine system also has a blow-by circuit provided with at least one pipe connecting the accumulation zone with the intake duct; at the same time, a sensor detects the pressure in the blow-by circuit, and an electronic control unit evaluates the pressure detected to indicate the presence of oil vapor leakage from the blow-by circuit; the blow-by circuit has an adjustment valve, which is arranged between the sensor and the intake duct, and is configured to have a passageway with an area that is automatically reduced in response to the underpressure caused by the engine during use.

Abstract: An apparatus (10) for detecting and monitoring nasal pressure is described comprising: a nasal probe (15) adapted to be permanently placed inside a patient's nostril, wherein the nasal probe (15) comprises: a support ring (20) which defines inside it a through opening (25) and provided with an external surface (22) adapted to come into contact with the patient's nostril, a housing seat (30) defined within the external surface (22) of the support ring (20) for housing the end of a cannula (75) adapted to be connected to a pressure transducer (100), and an inflatable membrane (35) associated with the support ring (20) and configured to be selectively moved between: a first configuration, in which it is inflated and completely occludes the through opening (25), and a second configuration, in which it is deflated and leaves at least partially open the through opening (25).

Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Abstract: The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Abstract: The present invention refers to sense and antisense peptide nucleic acids (PNAs). The present invention further refers to the use of said PNAs for preparing drugs for treating genetic diseases.

Abstract: The present invention refers to sense and antisense peptido-nucleic acids (PNAs). The present invention further refers to the use of said PNAs for preparing drugs for treating genetic diseases.